Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ear tube position may reduce surgery risks for kids

NCT ID NCT06191562

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at where ear tubes are placed in children with ear infections. Normally, tubes go in the front part of the eardrum, but this trial places them in the back part in one ear to see if it lowers the risk of a hole that won't heal. About 386 children will be followed for up to 3 years to compare complications like drainage, blockage, and persistent holes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
tympanostomy tube (ear tube)
What this could lead to
If successful, this could show that placing ear tubes in a different spot on the eardrum reduces the chance of a hole that won't close, making future repairs easier.
What could go wrong
This is a small, early-stage study comparing two surgical techniques, not testing a new drug. The benefit may be small, and results may not apply to all children.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 386 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2024

Expected to finish

Feb 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 months to 14 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Ages 6 months -14 years 2. Bilateral tympanostomy tube placement 3. First tympanostomy tubes placement 4. Indication for tympanostomy tube placement is otitis media Exclusion Criteria: 1. Undergoing tympanostomy tube placement for indication other than otitis media 2. Receiving tubes other than Armstrong grommet. 3. Genetic disorder that impacts the craniofacial structure, immune system, or mucosal secretions such as Downs syndrome, Stickler syndrome, Treacher Collins syndrome, other genetic disorder associated with craniofacial anomalies, Severe Combined Immunodeficiency disorder, Cystic Fibrosis, or Primary Ciliary Dyskinesia 4. Patients with craniofacial abnormalities other than plagiocephaly or submucous cleft palate (SMCP) 5. Caregivers who cannot speak, read, or write in English proficiently 6. Prior or current otologic surgery other than tympanostomy tube placement 7. On systemic corticosteroids at the time of enrollment 8. Immunodeficiency (acquired or congenital) 9. Current retraction, cholesteatoma, or middle ear mass 10. Atresia 11. Sensorineural hearing loss 12. Known ossicular chain anomaly

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic otitis media with effusion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, 15224, United States

  • UPMC Children's Hospital of Pittsburgh North

    Sewickley, Pennsylvania, 15143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.